110 related articles for article (PubMed ID: 28604655)
1. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
[TBL] [Abstract][Full Text] [Related]
2. TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level.
Yeo IJ; Yu JE; Kim SH; Kim DH; Jo M; Son DJ; Yun J; Han SB; Hong JT
Arch Pharm Res; 2024 Apr; 47(4):341-359. PubMed ID: 38592583
[TBL] [Abstract][Full Text] [Related]
3. TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung.
Ricci A; De Vitis C; Noto A; Fattore L; Mariotta S; Cherubini E; Roscilli G; Liguori G; Scognamiglio G; Rocco G; Botti G; Giarnieri E; Giovagnoli MR; De Toma G; Ciliberto G; Mancini R
Cell Cycle; 2013 Jun; 12(11):1696-703. PubMed ID: 23656788
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells.
Xiong X; Li Y; Liu L; Qi K; Zhang C; Chen Y; Fang J
Biol Res; 2018 Jun; 51(1):18. PubMed ID: 29898774
[TBL] [Abstract][Full Text] [Related]
5. Distinct requirements for TrkB and TrkC signaling in target innervation by sensory neurons.
Postigo A; Calella AM; Fritzsch B; Knipper M; Katz D; Eilers A; Schimmang T; Lewin GR; Klein R; Minichiello L
Genes Dev; 2002 Mar; 16(5):633-45. PubMed ID: 11877382
[TBL] [Abstract][Full Text] [Related]
6. Design of a Novel Gene Therapy Construct to Achieve Sustained Brain-Derived Neurotrophic Factor Signaling in Neurons.
Osborne A; Wang AXZ; Tassoni A; Widdowson PS; Martin KR
Hum Gene Ther; 2018 Jul; 29(7):828-841. PubMed ID: 29466871
[TBL] [Abstract][Full Text] [Related]
7. STAT3-BDNF-TrkB signalling promotes alveolar epithelial regeneration after lung injury.
Paris AJ; Hayer KE; Oved JH; Avgousti DC; Toulmin SA; Zepp JA; Zacharias WJ; Katzen JB; Basil MC; Kremp MM; Slamowitz AR; Jayachandran S; Sivakumar A; Dai N; Wang P; Frank DB; Eisenlohr LC; Cantu E; Beers MF; Weitzman MD; Morrisey EE; Worthen GS
Nat Cell Biol; 2020 Oct; 22(10):1197-1210. PubMed ID: 32989251
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms.
Joshi SK; Qian K; Bisson WH; Watanabe-Smith K; Huang A; Bottomly D; Traer E; Tyner JW; McWeeney SK; Davare MA; Druker BJ; Tognon CE
Blood; 2020 Jun; 135(24):2159-2170. PubMed ID: 32315394
[TBL] [Abstract][Full Text] [Related]
9. Effects of Chinese medicinal herbs on expression of brain-derived Neurotrophic factor (BDNF) and its interaction with human breast cancer MDA-MB-231 cells and endothelial HUVECs.
Chiu JH; Chen FP; Tsai YF; Lin MT; Tseng LM; Shyr YM
BMC Complement Altern Med; 2017 Aug; 17(1):401. PubMed ID: 28800782
[TBL] [Abstract][Full Text] [Related]
10. Fully human agonist antibodies to TrkB using autocrine cell-based selection from a combinatorial antibody library.
Merkouris S; Barde YA; Binley KE; Allen ND; Stepanov AV; Wu NC; Grande G; Lin CW; Li M; Nan X; Chacon-Fernandez P; DiStefano PS; Lindsay RM; Lerner RA; Xie J
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7023-E7032. PubMed ID: 29987039
[TBL] [Abstract][Full Text] [Related]
11. TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma.
Moriwaki K; Ayani Y; Kuwabara H; Terada T; Kawata R; Asahi M
Oncotarget; 2018 May; 9(38):25225-25243. PubMed ID: 29861866
[TBL] [Abstract][Full Text] [Related]
12. Chronic TrkB agonist treatment in old age does not mitigate diaphragm neuromuscular dysfunction.
Greising SM; Vasdev AK; Zhan WZ; Sieck GC; Mantilla CB
Physiol Rep; 2017 Jan; 5(1):. PubMed ID: 28082429
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic Analysis of the Interaction of the Low-Molecular-Weight BDNF Mimetic Dipeptide GSB-106 with TRK Receptors.
Antipova TA; Logvinov IO; Deyev IE; Povarnina PY; Vakhitova YV; Gudasheva TA; Seredenin SB
Dokl Biochem Biophys; 2023 Aug; 511(1):166-168. PubMed ID: 37833601
[TBL] [Abstract][Full Text] [Related]
14. TrkB Promotes Breast Cancer Metastasis via Suppression of Runx3 and Keap1 Expression.
Kim MS; Lee WS; Jin W
Mol Cells; 2016 Mar; 39(3):258-65. PubMed ID: 26657794
[TBL] [Abstract][Full Text] [Related]
15. A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways.
Pattwell SS; Arora S; Cimino PJ; Ozawa T; Szulzewsky F; Hoellerbauer P; Bonifert T; Hoffstrom BG; Boiani NE; Bolouri H; Correnti CE; Oldrini B; Silber JR; Squatrito M; Paddison PJ; Holland EC
Nat Commun; 2020 Jun; 11(1):2977. PubMed ID: 32532995
[TBL] [Abstract][Full Text] [Related]
16. Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.
Gomez DR; Byers LA; Nilsson M; Diao L; Wang J; Li L; Tong P; Hofstad M; Saigal B; Wistuba I; Kalhor N; Swisher S; Fan Y; Hong WK; Suraokar M; Behrens C; Moran C; Heymach JV
Oncotarget; 2018 Mar; 9(18):14268-14284. PubMed ID: 29581842
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling.
Cai S; Chen Q; Xu Y; Zhuang Q; Ji S
Transl Cancer Res; 2020 Mar; 9(3):1439-1447. PubMed ID: 35117491
[TBL] [Abstract][Full Text] [Related]
18. Novel CAR-T cells targeting TRKB for the treatment of solid cancer.
Liang D; Tang J; Sun B; He S; Yang D; Ma H; Yun Y; Zhu Y; Wei W; Chen H; Zhao X
Apoptosis; 2024 Mar; ():. PubMed ID: 38498249
[TBL] [Abstract][Full Text] [Related]
19. TrkB promotes laryngeal cancer metastasis via activation PI3K/AKT pathway.
Jiang L; Wang Z; Liu C; Gong Z; Yang Y; Kang H; Li Y; Hu G
Oncotarget; 2017 Dec; 8(65):108726-108737. PubMed ID: 29312563
[TBL] [Abstract][Full Text] [Related]
20. CCL19-Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase.
Schälter F; Azizov V; Frech M; Dürholz K; Schmid E; Hendel A; Sarfati I; Maeda Y; Sokolova M; Miyagawa I; Focke K; Sarter K; van Baarsen LGM; Krautwald S; Schett G; Zaiss MM
Arthritis Rheumatol; 2024 Jan; ():. PubMed ID: 38268500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
